Colin J. Sutherland

University of London — United Kingdom

Medicine · Health Sciences

70h-index14.4kcitations304works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(264), Mosquito-borne diseases and control(154), Computational Drug Discovery Methods(44), Parasites and Host Interactions(27), Vector-borne infectious diseases(26)

Publications304 total

Enhancing whole genome DNA amplification of Plasmodium falciparum for advanced molecular surveillance in malaria control
Malaria Journal·2025Open Access
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Zambia
BMC Infectious Diseases·2025Open Access
A novel intron variant is associated with emerging pfdhps mutant haplotypes in West and Central African Plasmodium falciparum
International Journal for Parasitology Drugs and Drug Resistance·2025Open Access
Global-scale population genetic analysis of Plasmodium falciparum identifies country- and region-specific patterns of malaria parasite adaptation
2025Open Access
Optimization and Characterization of the Antimalarial Activity of <i>N</i>-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1
Journal of Medicinal Chemistry·2025Open Access
Corrigendum to ‘A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections’
UNC Libraries·2025Open Access
A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections
UNC Libraries·2025Open Access
A case of <i>Plasmodium falciparum</i> malaria presenting 13 years after leaving an endemic area
Infectious Diseases·2025· 1 cited
Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
Nature Communications·2025· 5 citedOpen Access
Artemisinin Partial Resistance in Ugandan Children—Reply
JAMA·2025
Drug resistance–associated mutations in Plasmodium UBP-1 disrupt its essential deubiquitinating activity
Journal of Biological Chemistry·2025· 3 citedOpen Access
Blood Transfusions for Chronic Malaria Anemia in Prisoners of War on the Thai–Burma Railway 1943–1945
American Journal of Tropical Medicine and Hygiene·2025· 1 citedOpen Access
Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibility
Nature Communications·2024· 5 citedOpen Access
Genomic analysis of global Plasmodium vivax populations reveals insights into the evolution of drug resistance
Nature Communications·2024· 3 citedOpen Access
Population genomics of Plasmodium ovale species in sub-Saharan Africa
UNC Libraries·2024Open Access
The spread of molecular markers of artemisinin partial resistance and diagnostic evasion in Eritrea: a retrospective molecular epidemiology study
The Lancet Microbe·2024· 3 citedOpen Access
Population genomics of Plasmodium ovale species in sub-Saharan Africa
Nature Communications·2024· 6 citedOpen Access
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia
2024Open Access
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1
Nature Communications·2024Open Access
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Cameroon
BMC Infectious Diseases·2024· 5 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Teun Bousema(14), Chris Drakeley(14), Geoffrey Targett(10), Robert W. Sauerwein(9), Rachel Hallett(9), Khalid B. Beshir(8), Jean‐Bosco Ouédraogo(6), Taane G. Clark(6), Paul Milligan(6), Brian Greenwood(6), Issaka Zongo(5), Lucy Okell(5), Sabah A. Omar(5), Azra C. Ghani(5), Margaret Pinder(5), Rosalynn Ord(5), Debbie Nolder(5), Susana Campino(4), Abdoulaye Djimdé(4), Ogobara K. Doumbo(4)